Engineering researchers at the University of Arkansas have moved closer to developing an alternative method of detecting and possibly treating breast cancer. Terahertz images of breast tumors taken from mice accurately detected cancerous tissue with a high level of specificity.
Royal Philips, a global leader in health technology, and Hologic, Inc., an innovative women’s health company, announced a global partnership agreement to offer care professionals integrated solutions comprising diagnostic imaging modalities, advanced informatics and services for screening, diagnosis and treatment of women across the world. The collaboration combines Hologic’s innovative…
What beats digital mammography to detect breast cancer in asymptomatic women? Digital breast tomosynthesis (DBT) – was a big discussion at RSNA 2017. Sarah M Friedewald MD, medical director of the Lynn Sage Comprehensive Breast Center of Northwestern Memorial Hospital in Chicago and its division chief of breast and women’s imaging, discussed the clinical implications of DBT for routine…
Two new systems developed by Hologic Inc. recently received the European CE Mark: The MyoSure Manual and the Brevera Breast Biopsy System with CorLumina Imaging Technology.
The International Day of Radiology (IDoR) will be celebrated for the sixth time on November 8, this year focusing on emergency radiology. As in previous years, more than 150 radiology-related professional societies from around the world will participate in the International Day of Radiology, holding a range of different events to celebrate, such as public lectures, department open days, national…
A controversy regarding the benefit of early screening programmes for breast cancer continues. Germany, Austria and Switzerland have developed individual strategies. European Hospital asked three experts from these countries to outline each chosen system. Markus Hahn MD, senior consultant at the University Breast Centre in Tübingen, Martin Daniaux, MD, Head of Breast Diagnostics at the Breast…
Breast diagnostics are undergoing considerable change, with new technology facilitating alternative procedures. Genetics and nuclear medicine also enhance diagnostic possibilities. During our EH interview, Professor Rüdiger Schulz-Wendtland described current changes in breast diagnostics. ‘To date, complementary breast diagnostics has comprised clinical, sonographic and mammographic…
‘Clinicians across Europe have made clear their desire for breast cancer screening technology that offers improved accuracy, clarity and workflow, and the 3Dimensions system addresses each of those specific areas,’ Hologic’s Jan Verstreken, Regional President for EMEA and Canada, pointed out during the launch of the new system. This is the latest in the firm’s breast cancer screening,…
Despite rigorous quality assurance of breast cancer screening programs, ‘both, over- and under-diagnosis of breast cancer is a challenge,’ says leading radiologist Christiane K Kuhl, from the Department of Diagnostic and Interventional Radiology, at the University of Aachen, Germany. ‘Mammography is a good screening test – but has its limitations especially, but not only, in women with…
The European Society of Breast Imaging (ESOBI) promotes high quality breast imaging across Europe by developing education and training, encouraging research and promoting guidelines and standards. This year’s meeting (23-24 September) was held in collaboration with the French Society La Société d’Imagerie de la Femme (SIFEM) and drew around 600 radiologists. The event included a two-day…
Dr Massimo Calabrese, head of the Complex Operative Unit of Diagnostic Senology in Genoa’s San Martino Hospital, examines aspects of stereotactic breast biopsy procedures and workflow and the need for improvements in certain areas of breast diagnostics.
Access, accuracy and efficiency are at the core of Samsung’s healthcare strategy, explained Insuk Song, Vice President of Product Planning, Healthcare and Medical Equipment at Samsung Electronics, during our exclusive European Hospital interview. Samsung, the Korean giant, is now proceding with its artificial intelligence (AI) deployment, notably with the S-Detect software to help ultrasound…
Italian-led research has highlighted the value of utilising additional screening technologies to help diagnose breast cancer in some women. Interim analysis from the Adjunct Screening with Tomosynthesis or Ultrasound in Women with Mammography-Negative Dense Breasts (ASTOUND) study has delivered evidence of the potential benefit of adding either ultrasound or tomosynthesis to standard mammograms…
Breast tomosynthesis imaging, Hologic calls it 3-D mammography, is proving to be the best modality to image breast cancer. ‘The Hologic tomosynthesis system has demonstrated superior clinical performance to conventional 2-D mammography in a number of metrics, in particular showing improved detection of invasive cancers and reductions in recall rate,’ the manufacturer reports, adding: ‘Now…
Tomosynthesis is a breast cancer screening and diagnostic modality that acquires images of a breast at multiple angles during a short scan. The individual images are then reconstructed into a series of thin, high-resolution slices typically one mm thick.
Tomosynthesis is an advanced application that allows a multi-slice acquisition and provides a reconstruction of a volume. Several acquisitions at low dose are acquired with a single sweep of the X-Ray tube around the region of interest.
Results from recent trials are promising: an almost 40% increased breast cancer detection rate from digital breast tomosynthesis (DBT) screening compared to conventional mammography.
Using an iodinated contrast agent, I-View software on the Hologic tomosynthesis system enables the user to image the functional 2-D contrast uptake and the morphological mammography images in rapid sequence and combine these three image sets into a single co-registered study.
At the recent North American IHE Connectathon in Cleveland, Sectra (STO: SECT B) successfully completed testing of the IHE profiles MAMMO and DBT (Digital Breast Tomosynthesis). The testing was done using Sectra PACS which implements the Image Display and Image Manager actors of these profiles.
Carestream will show enhancements to its digital breast tomosynthesis (DBT) module including a slabbing tool, improved workflow capabilities and the display of DICOM-compliant 2D synthetic views (which are generated from the 3D dataset) at the 2015 European Conference of Radiology. The latest DBT module is currently available.
Carestream scientist Dr Samuel Richard will present a scientific paper documenting the impact of advanced imaging technologies on lung nodule conspicuity at the 2015 European Congress of Radiology (ECR).
Digital breast tomosynthesis offers a number of benefits over other modalities but challenges remain in its optimum clinical application.
Dr Martínez Miravete didn’t set out to change breast imaging in Spain when she first adopted breast tomosynthesis.
Over the decades of breast imaging numerous studies have shown that radiation free and inexpensive ultrasound can detect some subtle cancers not visible on a mammography exam.
There is little evidence on respiratory support with extracorporeal systems – enough of an argument for most of those doubting the procedure not to use it, or even make it available.